| Overview |
| bs-43192P-Biotin-100ug |
| Recombinant SARS-Cov-2 Spike protein(BA.2.86), (HEK293), Biotin Conjugated |
| Others |
| Others |
| Specifications |
| Biotin |
| Recombinant SARS-Cov-2 Spike protein(BA.2.86) is expressed in HEK293 cell with C-T4 foldon domain&His. It contains the amino acid sequence of 16-1213/1273 |
| Lyophilized from 0.22um filtered solution in 20mM PB (pH 7.4). 5% trehalose is added as a protectant before lyophilization. |
| Target |
| P0DTC2 |
| The SARS-CoV-2 spike (S) protein is the target of vaccine design efforts to end the COVID-19 pandemic. Despite a low mutation rate, isolates with the D614G substitution in the S protein appeared early during the pandemic, and are now the dominant form worldwide. Here, we analyze the D614G mutation in the context of a soluble S ectodomain construct. |
Powered by Bioz